Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb;144(1):205-12.
doi: 10.1007/s10549-014-2862-5. Epub 2014 Feb 8.

Sclerosing adenosis and risk of breast cancer

Affiliations

Sclerosing adenosis and risk of breast cancer

Daniel W Visscher et al. Breast Cancer Res Treat. 2014 Feb.

Abstract

Over one million American women have a benign breast biopsy annually. Sclerosing adenosis (SA) is a common, but poorly understood benign breast lesion demonstrating increased numbers of distorted lobules accompanied by stromal fibrosis. Few studies of its association with breast cancer have been conducted, with contradictory results. We studied SA in the Mayo Benign Breast Disease (BBD) Cohort, which includes women who had benign biopsies at Mayo-Rochester 1967-2001. Breast cancer risk in defined subsets was assessed using standardized incidence ratios (SIRs), relative to the Iowa Surveillance, Epidemiology, and End Results registry. This BBD cohort of 13,434 women was followed for a median of 15.7 years. SA was present in 3,733 women (27.8 %) who demonstrated an SIR for breast cancer of 2.10 (95 % CI 1.91-2.30) versus an SIR of 1.52 (95 % CI 1.42-1.63) for the 9,701 women without SA. SA was present in 62.4 % of biopsies with proliferative disease without atypia and 55.1 % of biopsies with atypical hyperplasia. The presence of SA stratified risk in subsets of women defined by age, involution status, and family history. However, SA does not further stratify risk in women diagnosed with other forms of proliferative breast disease, either with or without atypia. SA is a common proliferative lesion of the breast which, as a single feature, conveys an approximate doubling of breast cancer risk. Its role in breast carcinogenesis remains undefined; its presence may aid in risk prediction for women after a breast biopsy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
×20 photomicrographs of sclerosing adenosis. a Large, central area of SA (arrow), with diameter larger than the normal lobular units pictured to the right (arrow heads). This SA would be classified as PDWA. b A lobular unit with sclerosing adenosis but without significant increase in its diameter (arrow): compare with normal lobular unit (arrow heads). This would be classified as NP
Fig. 2
Fig. 2
Mixed adenosis/columnar lesion. a Low-magnification (×100) view shows a markedly enlarged terminal duct lobular unit comprised of admixed microacini (adenosis)with larger cystic acini lined by columnar cells. b Higher-magnification (×200) photomicrograph of the same lobule highlighting columnar acini (left) and smaller microacini characteristic of adenosis (right). Microcalcifications are present
Fig. 3
Fig. 3
Risk factor interaction profiles for sclerosing adenosis, comparing the number of events observed with the number expected. a Age and sclerosing adenosis, b Histology and SA, c Extent of lobular involution and SA, d Columnar cell alterations and SA, and e Family history and SA

Similar articles

Cited by

References

    1. Santen RJ, Mansel R. Benign breast disorders. N Engl J Med. 2005;353(3):275–285. doi: 10.1056/NEJMra035692. - DOI - PubMed
    1. Jensen RA, Page DL, Dupont WD, et al. Invasive breast cancer risk in women with sclerosing adenosis. Cancer. 1989;64:1977–1983. doi: 10.1002/1097-0142(19891115)64:10<1977::AID-CNCR2820641002>3.0.CO;2-N. - DOI - PubMed
    1. Shaaban AM, Sloane JP, West CR, Moore FR, Jarvis C, Williams EM, Foster CS. Histopathologic types of benign breast lesions and the risk of breast cancer: case–control study. Am J Surg Pathol. 2002;26(4):421–430. doi: 10.1097/00000478-200204000-00003. - DOI - PubMed
    1. Kabat GC, Jones JG, Olson NK, Negassa A, Duggan C, Ginsberg M, Kandel RA, Glass AG, Rohan TE. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control. 2010;21(6):821–828. doi: 10.1007/s10552-010-9508-7. - DOI - PMC - PubMed
    1. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353(3):229–237. doi: 10.1056/NEJMoa044383. - DOI - PubMed

Publication types